Abstract
Simple Summary Non-small-cell lung cancer (NSCLC) patients become resistant to targeted therapies such as tyrosine kinase inhibitors (TKIs) through mu......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
